Physician profile
Thomas Steineke
NPI 1477553782
$2,824.26
in general payments reported to CMS, 2019-2025
21 companies · $318 in 2025
The $318 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $59.21 · 2021: $767 · 2022: $391 · 2023: $989 · 2024: $134 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,441.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgical Theater. INC. | $1,400.01 | 2021-2025 | |
| Depuy Synthes Sales INC. | $276.64 | 2019-2023 | Spine & Trauma 3d Navigation |
| Medtronic, INC. | $195.11 | 2022-2023 | Mazor X System, Synchromedii |
| Abbott Laboratories | $137.60 | 2022 | |
| Novocure INC. | $136.63 | 2021-2023 | Optune |
| Ambu INC. | $117.87 | 2023 | |
| Intuitive Surgical, INC. | $100.33 | 2023 | |
| Sk Life Science, INC. | $93.59 | 2022-2023 | |
| Medtronic USA, INC. | $92.02 | 2019 | |
| Livanova USA, INC. | $69.25 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Argenx US, INC. | $34.50 | 2022-2024 | Vyvgart Hytrulo |
| Monteris Medical Corporation | $34.15 | 2022 | |
| Lilly USA, LLC | $17.46 | 2022 | |
| Harmony Biosciences LLC | $16.19 | 2023 | Wakix |
| Sanara Medtech INC. | $16.16 | 2025 | Celleraterx |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $15.58 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $15.11 | 2023 | Austedo Xr |
| Ucb, INC. | $14.20 | 2023 | Briviact |
| Zimvie INC. | $14.20 | 2023 | |
| Abbvie INC. | $13.87 | 2025 | |
| Kyowa Kirin, INC. | $13.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Steineke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.